46716 Federal Register / Vol. 86, No. 158 / Thursday, August 19, 2021 / Notices 

Commission is properly sought will be 

treated accordingly. All information, 

including confidential business 

information and documents for which 

confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this Investigation may be 

disclosed to and used: (i) By the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. Appendix 3; or (ii) by U.S. 

government employees and contract 

personnel, solely for cybersecurity 

purposes. All contract personnel will 

sign appropriate nondisclosure 

agreements. All nonconfidential written 

submissions will be available for public 

inspection on EDIS. 

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and Part 210 of the Commission’s Rules 

of Practice and Procedure (19 CFR part 

210). 

By order of the Commission. 

Issued: August 16, 2021. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2021–17816 Filed 8–18–21; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–887] 

Importer of Controlled Substances 

Application: Galephar Pharmaceutical 

Research Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Galephar has applied to be 

registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to SUPPLEMENTARY INFORMATION

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before September 20, 2021. Such 

persons may also file a written request 

for a hearing on the application on or 

before September 20, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for a 

hearing should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on July 23, 2021, Galephar 

Pharmaceutical Research Inc., 100 Carr 

198 Industrial Park, Juncos, Puerto Rico 

00777–3873, applied to be registered as 

an importer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Hydromorphone .............. 9150 II 

The company plans to import the 

listed controlled substance in finished 

dosage form for analytical purpose only. 

No other activity for this drug code is 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Brian S. Besser, 

Acting Assistant Administrator. 

[FR Doc. 2021–17765 Filed 8–18–21; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–886] 

Importer of Controlled Substances 

Application: Chattem Chemicals, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Chattem Chemicals, Inc., has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before September 20, 2021. Such 

persons may also file a written request 

for a hearing on the application on or 

before September 20, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for a 

hearing should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on July 23, 2021, Chattem 

Chemicals, Inc., 3801 Saint Elmo 

Avenue, Chattanooga, Tennessee 

37409–1237, applied to be registered as 

an importer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Methamphetamine ........... 1105 II 

4-Anilino-N-Phenethyl-4- 

Piperidine (ANPP).

8333 II 

Phenylacetone ................. 8501 II 

Coca Leaves ................... 9040 II 

Opium, Raw ..................... 9600 II 

Poppy Straw Concentrate 9670 II 

Tapentadol ...................... 9780 II 

The company plans to import the listed 

controlled substances to manufacture 

bulk controlled substances for sale to its 

customers. The company plans to 

import an intermediate of Tapentadol 

(9780), to bulk manufacture Tapentadol 

for distribution to its customers. No 

other activity for this drug code is 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonVerDate Sep<11>2014 17:28 Aug 18, 2021 Jkt 253001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 E:\FR\FM\19AUN1.SGM 19AUN1

lotter on DSK11XQN23PROD with NOTICES1

I I 
Federal Register / Vol. 86, No. 158 / Thursday, August 19, 2021 / Notices 46717 

approved finished dosage forms for 

commercial sale. 

Brian S. Besser, 

Acting Assistant Administrator. 

[FR Doc. 2021–17764 Filed 8–18–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF LABOR 

Office of Disability Employment Policy 

Agency Information Collection 

Activities; Comment Request; Job 

Accommodation Network Customer 

Satisfaction Questionnaire 

ACTION: Notice of information 

collections and request for comments. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

DOL is soliciting public comments 

regarding this ODEP-sponsored 

information collection to the Office of 

Management and Budget (OMB) for 

review and approval. 

DATES: Comments pertaining to this 

information collection are due on or 

before October 18, 2021. 

ADDRESSES: Electronic submission: You 

may submit comments and attachments 

electronically at http://

www.regulations.gov. Follow the online 

instructions for submitting comments. 

Mail submission: 200 Constitution 

Ave. NW, Room S–5315, Washington, 

DC 20210. Comments are invited on: (1) 

Whether the collection of information is 

necessary for the proper performance of 

the functions of the DOL, including 

whether the information will have 

practical utility; (2) if the information 

will be processed and used in a timely 

manner; (3) the accuracy of the DOL’s 

estimates of the burden and cost of the 

collection of information, including the 

validity of the methodology and 

assumptions used; (4) ways to enhance 

the quality, utility and clarity of the 

information collection; and (5) ways to 

minimize the burden of the collection of 

information on those who are to 

respond, including the use of automated 

collection techniques or other forms of 

information technology. 

FOR FURTHER INFORMATION CONTACT: 

Betsy Kravitz by telephone at 202–693– 

7860 (this is not a toll-free number) or 

by email at DOL_PRA_PUBLIC@dol.gov. 

SUPPLEMENTARY INFORMATION: The Job 

Accommodation Network (JAN) is a 

leading source of guidance on job 

accommodations and disability 

employment issues and has served 

customers for more than 35 years. JAN 

provides free one-on-one practical 

guidance and technical assistance on job 

accommodation solutions, Title I of the 

Americans with Disabilities Act (ADA) 

and related legislation, and selfemployment and entrepreneurship 

options for people with disabilities. JAN 

provides individualized consultation to 

assist: 

• Employers and their representatives 

seeking guidance on practical ways to 

engage in the interactive process, 

provide job accommodation solutions, 

and comply with Title I of the ADA; 

• Individuals with medical 

conditions and disabilities seeking 

information about job accommodation 

solutions, employment rights under the 

ADA, and self-employment and 

entrepreneurship opportunities; and 

• Family members and rehabilitation, 

medical, educational, and other 

professionals in their effort to support 

successful employment outcomes for 

individuals with medical conditions 

and disabilities. 

JAN customers (employer 

representatives, service providers, and 

individuals with disabilities) who 

contact JAN via phone calls, email, and 

internet chats and who have inquiries 

related to workplace accommodation or 

self-employment issues will be asked to 

participate in the Customer Satisfaction 

Questionnaire, which is sent via email. 

The initial email requesting 

participation includes the Informed 

Consent script used by both JAN and the 

West Virginia University School of 

Social Work. Informed consent specifies 

that the purpose is to evaluate JAN’s 

services and to identify ways in which 

services can be improved to assist 

clients. Potential participants also will 

be informed that their decision to either 

participate or refuse to participate will 

in no way impact their ability to use 

JAN’s services in the future. Following 

the link to complete the questionnaire is 

considered consent. Customers can also 

opt out of further contacts or choose to 

contact the evaluator directly if there are 

questions or concerns. The statement 

has been approved by the West Virginia 

University Internal Review Board. The 

questionnaire requests demographic 

information, accommodation process 

details and costs, and general 

satisfaction items. Respondents can 

choose to answer or skip each item. 

This information collection is subject 

to the Paperwork Reduction Act (PRA). 

A Federal agency generally cannot 

conduct or sponsor a collection of 

information, and the public is generally 

not required to respond to an 

information collection, unless the OMB 

approves it and displays a currently 

valid OMB Control Number. In addition, 

notwithstanding any other provisions of 

law, no person shall generally be subject 

to penalty for failing to comply with a 

collection of information that does not 

display a valid OMB Control Number. 

See 5 CFR 1320.5(a) and 1320.6. 

The DOL seeks PRA authorization for 

this information collection for three (3) 

years. OMB authorization for an 

Information Collection Review cannot 

be for more than three (3) years without 

renewal. The DOL notes that currently 

approved information collection 

requirements submitted to the OMB 

receive a month-to-month extension 

while they undergo review. 

Agency: DOL–ODEP. 

Type of Review: New information 

collection. 

Title of Collection: Job 

Accommodation Network (JAN) 

Customer Satisfaction Questionnaire. 

OMB Control Number: 1230–0NEW. 

Affected Public: Individuals or 

Households. 

Total Estimated Number of 

Respondents: 1,680. 

Frequency: Once per customer every 6 

months. 

Total Estimated Number of 

Responses: 1,680. 

Total Estimated Annual Time Burden: 

420 hours. 

Total Estimated Annual Other Costs 

Burden: $0. 

Authority: 44 U.S.C. 3506(c)(2)(A). 

Dated: August 12, 2021. 

Jennifer Sheehy, 

Deputy Assistant Secretary, Office of 

Disability Employment Policy. 

[FR Doc. 2021–17787 Filed 8–18–21; 8:45 am] 

BILLING CODE 4510–FK–P 

DEPARTMENT OF LABOR 

Employment and Training 

Administration 

Determinations Regarding Eligibility 

To Apply for Trade Adjustment 

Assistance 

In accordance with Sections 223 and 

284 (19 U.S.C. 2273 and 2395) of the 

Trade Act of 1974 (19 U.S.C. 2271, et 

seq.) (‘‘Act’’), as amended, the 

Department of Labor herein presents 

summaries of determinations regarding 

eligibility to apply for trade adjustment 

assistance under Chapter 2 of the Act 

(‘‘TAA’’) for workers by (TA–W) issued 

during the period of July 1 2021 through 

July 31 2021. 

This notice includes summaries of 

initial determinations such as 

Affirmative Determinations of 

Eligibility, Negative Determinations of 

Eligibility, and Determinations 

Terminating Investigations of Eligibility 

within the period. If issued in the 


lotter on DSK11XQN23PROD with NOTICES1